Mobile intervention for emerging adults with regular cannabis use: a micro-randomized trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 42306078.
- Also identified by DOI 10.1016/j.lana.2026.101524 and PMC identifier 13267558.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cannabis use is prevalent among emerging adults, with regular use increasing risk for problems; yet few seek treatment. Using a micro-randomized trial (MRT), the study aims were to test a <i>personalizing</i> just-in-time adaptive interventions (pJITAI), which is powered by a reinforcement learning (RL) algorithm to improve the JITAI in real-time. Emerging adults (N = 122) with regular cannabis use were enrolled in a 30-day MRT, and completed a 1-month post-test and 2-month follow-up (e.g., after MRT start; NCT05824754). During the MRT, participants were prompted to complete twice-daily surveys, followed by twice-daily micro-randomizations to intervention message or no message (probabilities determined by the RL algorithm). Primary outcomes were 1-month feasibility and acceptability; MRT results were examined for the effect of intervention message delivery (vs. not) on proximal intervention engagement and cannabis use (next decision point; intent-to-treat). The app was feasible (89.1% (n = 122/137) downloaded; 77.1% (5642/7320) of twice-daily surveys completed, and acceptable (80.4% (n = 90/112) positively rated the messages for care, support, warmth, and respect). In MRT analyses, delivering a message (vs. not) increased proximal engagement (<i>b</i> = 0.044; 95% CI: 0.018, 0.070) but did not affect proximal cannabis use (<i>b</i> = 0.008; 95% CI: -0.003, 0.020). A clinically meaningful negative correlation was found between average engagement and cannabis use days at 2-months (<i>b</i> = -3.38; 95% CI: -8.68, 1.91). The pJITAI is promising among not-in-treatment emerging adults, with messages increasing engagement, warranting further refinement to optimize this intervention. Research was supported by the National Institute of Health [(P50DA054039; K23AA028232; T32AA007477; K23DA059484; P41EB028242] and the Brzoznowski family.